Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls

Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls

BackgroundSchizophrenia (SZ) and bipolar disorder (BD) share many features: overlap in mood and psychotic symptoms, common genetic predisposition, treatment with antipsychotics (APs), and similar metabolic comorbidities. The pathophysiology of both is still not well defined, and no biomarkers can be...

Full description

Bibliographic Details
Main Authors: Rudolf Engelke, Sami Ouanes, Suhaila Ghuloum, Rifka Chamali, Nancy Kiwan, Hina Sarwath, Frank Schmidt, Karsten Suhre, Hassen Al-Amin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Psychiatry
Subjects:
proteomics
antipsychotics
schizophrenia
bipolar disorder
biomarkers
metabolic syndrome
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.809071/full

Similar Items

Similar Items